Presenting Author
Vanderbilt University Medical Center
CURRENT POSITION:
Postdoctoral Research Fellow at Vanderbilt University Medical Center in the Department of Medicine, Allergy, Pulmonary & Critical Care Division Vanderbilt University. Nashville Ten., USA
POST SECONDARY EDUCATION:
Ph.D. Physiology & Pharmacology (2016—2021) at the University of Western Ontario in the Department of Physiology & Pharmacology. London, Ont., Canada. Supervisor: Dr Ruud Veldhuizen & Cory Yamashita. Thesis: Exogenous Surfactant as a Drug Delivery Vehicle for Intrapulmonary Therapeutics
Bachelor of Biological and Medical Science (2011—2016) at the University of Western Ontario. Honors Specialization in Medical Sciences. Western Scholar.
RESEARCH TRAINING
Research Assistant (2014-2016) at Lawson Research Institute, St Joseph’s Hospital. London Ont. Canada.
Supervisor: Dr. Cory Yamashita & Dr. Ruud Veldhuizen
Topics: 1) Exogenous surfactant supplementation and ex vivo lung perfusion on donor lungs damaged by gastric acid aspiration & 2) The Biophysical Alterations to Pulmonary Surfactant during Lung Injury.
PUBLICATIONS:
Original Articles:
1) Baer B, McCaig L, Yamashita C, Veldhuizen R, (2020) Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo. Lung. 198(6):909-916. doi: 10.1007/s00408-020-00399-2.
2) Veldhuizen R, Baer B, McCaig L, Solomon LA, Cameron L, and Hardy DB. (2020) The effect of maternal protein restriction during perinatal life on the inflammatory response in pediatric rats. Can J. Physiol. Pharmacol. 99(5): 556-560. doi:10.1139/cjpp-2020-0431
3) Baer B, Veldhuizen EJA, Molchanova N, Jekhmane S, Weingarth M, Jenssen H, Lin JS, Barron AE, Yamashita C, and Veldhuizen R. (2020) Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2. Sci Rep. 10: 9392. doi: 10.1038/s41598-020-66448-1141cd938-37b8-4792-90d5-bc9b47451326.
4) Baer B, Veldhuizen EJA, Possmayer F, Yamashita C, and Veldhuizen R. (2018) The Wet Bridge Transfer System: A Novel Tool to Assess Exogenous Surfactant as a Vehicle for Intrapulmonary Drug Delivery. Discovery Medicine. 26 (144): 207-218. PMID: 30695680.
5) Banaschewski BJH, Baer B, Arsenault C, Jazey T, Veldhuizen EJA, Delport J, Gooyers T, Lewis JF, Haagsman HP, Veldhuizen RAW, and Yamashita C. (2017) The Antibacterial and Anti-inflammatory Activity of Chicken Cathelicidin-2 combined with Exogenous Surfactant for the Treatment of Cystic Fibrosis-Associated Pathogens. Sci Rep. 14 (7): 15545. doi: 10.1038/s41598-017-15558-4.
6) Coorens M, Banaschewski BJH, Baer BJ, Yamashita C, Van Dijk A, Haagsman HP, Veldhuizen RAW, and Veldhuizen EJA. (2017) Killing of P. aeruginosa by chicken cathelicidin-2 prevents lung inflammation in vivo. Infection and Immunity 85(12): e00546-17. doi: 10.1128/IAI.00546-17.
7) Nakajima D, Liu M, Ohsumi A, Kalaf R, Iskender I, Hsin M, Kanou T, Chen M, Baer B, Coutinho R, Maahs L, Behrens P, Azad S, Martinu T, Waddell TK, Lewis JF, Post M, Veldhuizen RAW, Cypel M, Keshavjee S. (2016) Lung Lavage and Surfactant Replacement During Ex Vivo Lung Perfusion for Treatment of Gastric Acid Aspiration-Induced Donor Lung Injury. J Heart Lung Transplant. 36: 577-585. doi: 10.1016/j.healun.2016.11.010.
Review Articles:
1) Baer B, Souza LMP, Pimentel AS, Veldhuizen RAW. (2019). New insights into exogenous surfactant as a carrier of pulmonary therapeutics. Biochemical Pharmacology, 164: 64-73 doi: 10.1016/j.bcp.2019.03.036.